maintenance phase

maintenance phase

IPT for PTSD—Termination Phase and Maintenance

σ s regulates pLS 1 maintenance in stationary-phase Escherichia coli

Identifying the target NSCLC patient for maintenance therapy: an analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN)†

A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer

P-307Immunomodulatory switch maintenance therapy to improve overall survival in metastatic colorectal carcinoma: The phase 3 IMPALA study

P-308RAVELLO trial: Phase III study of regorafenib versus placebo as maintenance therapy in RAS wild type metastatic colorectal cancer

P-0268THE RANDOMIZED PHASE 3 IMPALA STUDY: IMMUNOMODULATORY MAINTENANCE THERAPY WITH TLR-9 AGONIST MGN1703 IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA

Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials

Electronic Monitoring of Medication Adherence in Early Maintenance Phase Treatment for Pediatric Leukemia and Lymphoma: Identifying Patterns of Nonadherence

Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases

Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study

Phase II clinical trial with axitinib as maintenance therapy in patients (p) with metastatic colorectal carcinoma (CRC)

Randomized controlled phase II trial of S-1 maintenance therapy in Caucasian population with metastatic esophagogastric cancer– the multinational MATEO study

SP554ANKLE-BRACHIAL INDEX AND SKIN PERFUSION PRESSURE : WHICH IS THE STRONGER PREDICTOR OF LIFE PROGNOSIS AMONG MAINTENANCE-PHASE HEMODIALYSIS PATIENTS?

SP691PREDICTING CLINICAL OUTCOMES USING PHASE ANGLE AS ASSESSED BY BIOELECTRICAL iMPEDANCE ANALYSIS IN MAINTENANCE HEMODIALYSIS PATIENTS

986TiPA randomized, double-blind, placebo-controlled multicenter phase 3 trial of niraparib maintenance treatment in patients with advanced ovarian cancer following frontline chemotherapy

1527OTop-line data from the randomized phase 2 IMPULSE study in small-cell lung cancer (SCLC): Immunotherapeutic maintenance treatment with lefitolimod

987TiPOReO/ENGOT Ov-38: A phase IIIb trial of olaparib maintenance retreatment in patients with epithelial ovarian cancer